Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wolfson

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Arthritis Care & Research|November 26, 2015
Effects of Reductions in Body Mass Index on the Future Osteoarthritis Burden in Canada: A Population-Based Microsimulation StudyJacek A Kopec, Eric C Sayre, Philippe Fines, et al.
Health Reports|May 21, 2015
Performance of the cancer risk management model lung cancer screening moduleWilliam M Flanagan, William K Evans, Natalie R Fitzgerald, et al.
BMJ (Clinical Research Ed.)|March 31, 2000
Relation between income inequality and mortality in Canada and in the United States: cross sectional assessment using census data and vital statisticsN A Ross, M C Wolfson, J R Dunn, et al.
NMR in Biomedicine|December 1, 1996
Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patientsL Fu, C Wolfson, K J Worsley, et al.
Current Oncology (Toronto, Ont.)|June 23, 2016
Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and durationW K Evans, W M Flanagan, A B Miller, et al.
Stroke|August 6, 2000
Hemostatic markers in patients at risk of cerebral ischemiaR Côté, C Wolfson, S Solymoss, et al.
Annals of Neurology|July 1, 1994
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosisD L Arnold, G T Riess, P M Matthews, et al.
JAMA Oncology|July 31, 2015
Cost-effectiveness of Lung Cancer Screening in CanadaJohn R Goffin, William M Flanagan, Anthony B Miller, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectivenessJohn R Goffin, William M Flanagan, Anthony B Miller, et al.
British Journal of Cancer|November 27, 2001
First do no harm: extending the debate on the provision of preventive tamoxifenB P Will, K M Nobrega, J M Berthelot, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Arthritis Care & Research|November 26, 2015
Effects of Reductions in Body Mass Index on the Future Osteoarthritis Burden in Canada: A Population-Based Microsimulation StudyJacek A Kopec, Eric C Sayre, Philippe Fines, et al.
Health Reports|May 21, 2015
Performance of the cancer risk management model lung cancer screening moduleWilliam M Flanagan, William K Evans, Natalie R Fitzgerald, et al.
BMJ (Clinical Research Ed.)|March 31, 2000
Relation between income inequality and mortality in Canada and in the United States: cross sectional assessment using census data and vital statisticsN A Ross, M C Wolfson, J R Dunn, et al.
NMR in Biomedicine|December 1, 1996
Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patientsL Fu, C Wolfson, K J Worsley, et al.
Current Oncology (Toronto, Ont.)|June 23, 2016
Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and durationW K Evans, W M Flanagan, A B Miller, et al.
Stroke|August 6, 2000
Hemostatic markers in patients at risk of cerebral ischemiaR Côté, C Wolfson, S Solymoss, et al.
Annals of Neurology|July 1, 1994
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosisD L Arnold, G T Riess, P M Matthews, et al.
JAMA Oncology|July 31, 2015
Cost-effectiveness of Lung Cancer Screening in CanadaJohn R Goffin, William M Flanagan, Anthony B Miller, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectivenessJohn R Goffin, William M Flanagan, Anthony B Miller, et al.
British Journal of Cancer|November 27, 2001
First do no harm: extending the debate on the provision of preventive tamoxifenB P Will, K M Nobrega, J M Berthelot, et al.
Pageof 11